Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 2/20 | 0.48 |
| ▸ | NPY1R | P25929 | 1/20 | 0.47 |
| ▸ | NPY2R | P49146 | 1/20 | 0.47 |
| ▸ | NPY4R | P50391 | 1/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.47 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.47 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.45 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.45 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.45 |
| ▸ | NTSR2 | O95665 | 11/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 11/20 | 0.44 |
| ▸ | SORT1 | Q99523 | 9/20 | 0.44 |
| ▸ | REN | P00797 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29678075 | 0.95 | MAPK8 (0.47) | CAPN1CALCRLMAPK8MAPK9MAPK10 | |
| SCHEMBL29976151 | 0.92 | CALCRL (0.44) | CAPN1CALCRLNTSR2NTSR1SORT1 | |
| SCHEMBL29678210 | 0.89 | NPY1R (0.58) | NPY1RNPY2RNPY4RNPY5RCALCRL | |
| SCHEMBL29590984 | 0.82 | NTSR2 (0.49) | CAPN1NTSR2NTSR1SORT1REN | |
| SCHEMBL30988889 | 0.81 | CALCRL (0.49) | CAPN1CALCRLREN | |
| SCHEMBL31026618 | 0.81 | NTSR1 (0.49) | CAPN1CALCRLMAPK8MAPK9MAPK10 | |
| SCHEMBL29625336 | 0.80 | XIAP (0.53) | NPY1RNPY2RNPY4RNPY5RNTSR2 | |
| SCHEMBL31257014 | 0.79 | XIAP (0.54) | CALCRLMAPK8MAPK9MAPK10NTSR2 | |
| SCHEMBL29611754 | 0.79 | CAPN1 (0.49) | CAPN1CALCRLMAPK8MAPK9MAPK10 | |
| SCHEMBL29614726 | 0.79 | NTSR2 (0.51) | CAPN1NPY1RNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003403-A1 | RECEPTOR-TARGETING PEPTIDE-DRUG CONJUGATES | Molgenie GmbH (DE) | 2022-06-01 | — | — | EP | claimed |